使用机器学习方法通过 16 个预后相关基因特征识别 WHO II/III 胶质瘤

Molinaro, A.M.; Taylor, J.W.; Wiencke, J.K.; Wrensch, M.R. Genetic and molecular epidemiology of adult diffuse glioma. Nat. Rev. Neurol., 2019, 15(7), 405-417.
[http://dx.doi.org/10.1038/s41582-019-0220-2] [PMID: 31227792]

Rasmussen, B.K.; Hansen, S.; Laursen, R.J.; Kosteljanetz, M.; Schultz, H.; Nørgård, B.M.; Guldberg, R.; Gradel, K.O. Epidemiology of glioma: Clinical characteristics, symptoms, and predictors of glioma patients grade I-IV in the the Danish Neuro-Oncology Registry. J. Neurooncol., 2017, 135(3), 571-579.
[http://dx.doi.org/10.1007/s11060-017-2607-5] [PMID: 28861666]

Louis, D.N.; Perry, A.; Reifenberger, G.; von Deimling, A.; Figarella-Branger, D.; Cavenee, W.K.; Ohgaki, H.; Wiestler, O.D.; Kleihues, P.; Ellison, D.W. The 2016 world health organization classification of tumors of the central nervous system: A summary. Acta Neuropathol., 2016, 131(6), 803-820.
[http://dx.doi.org/10.1007/s00401-016-1545-1] [PMID: 27157931]

Ostrom, Q.T.; Gittleman, H.; Stetson, L.; Virk, S.M.; Barnholtz-Sloan, J.S. Epidemiology of Gliomas. .Cancer treatment and research; Raizer, J.; Parsa, A., Eds.; Springer International Publishing: Cham,, 2015, 163, pp. 1-14.

Jiang, T.; Nam, D.H.; Ram, Z.; Poon, W.S.; Wang, J.; Boldbaatar, D.; Mao, Y.; Ma, W.; Mao, Q.; You, Y.; Jiang, C.; Yang, X.; Kang, C.; Qiu, X.; Li, W.; Li, S.; Chen, L.; Li, X.; Liu, Z.; Wang, W.; Bai, H.; Yao, Y.; Li, S.; Wu, A.; Sai, K.; Li, G.; Yao, K.; Wei, X.; Liu, X.; Zhang, Z.; Dai, Y.; Lv, S.; Wang, L.; Lin, Z.; Dong, J.; Xu, G.; Ma, X.; Zhang, W.; Zhang, C.; Chen, B.; You, G.; Wang, Y.; Wang, Y.; Bao, Z.; Yang, P.; Fan, X.; Liu, X.; Zhao, Z.; Wang, Z.; Li, Y.; Wang, Z.; Li, G.; Fang, S.; Li, L.; Liu, Y.; Liu, S.; Shan, X.; Liu, Y.; Chai, R.; Hu, H.; Chen, J.; Yan, W.; Cai, J.; Wang, H.; Chen, L.; Yang, Y.; Wang, Y.; Han, L.; Wang, Q. Clinical practice guidelines for the management of adult diffuse gliomas. Cancer Lett., 2021, 499, 60-72.
[http://dx.doi.org/10.1016/j.canlet.2020.10.050] [PMID: 33166616]

Yang, P.; Cai, J.; Yan, W.; Zhang, W.; Wang, Y.; Chen, B.; Li, G.; Li, S.; Wu, C.; Yao, K.; Li, W.; Peng, X.; You, Y.; Chen, L.; Jiang, C.; Qiu, X.; Jiang, T. Classification based on mutations of TERT promoter and IDH characterizes subtypes in grade II/III gliomas. Neuro-oncol., 2016, 18(8), 1099-1108.
[http://dx.doi.org/10.1093/neuonc/now021] [PMID: 26957363]

Colman, H.; Zhang, L.; Sulman, E.P.; McDonald, J.M.; Shooshtari, N.L.; Rivera, A.; Popoff, S.; Nutt, C.L.; Louis, D.N.; Cairncross, J.G.; Gilbert, M.R.; Phillips, H.S.; Mehta, M.P.; Chakravarti, A.; Pelloski, C.E.; Bhat, K.; Feuerstein, B.G.; Jenkins, R.B.; Aldape, K. A multigene predictor of outcome in glioblastoma. Neuro-oncol., 2010, 12(1), 49-57.
[http://dx.doi.org/10.1093/neuonc/nop007] [PMID: 20150367]

Zhao, J.; Wang, L.; Hu, G.; Wei, B.A. 6-Gene Risk Signature Predicts Survival of Glioblastoma Multiforme. BioMed Res. Int., 2019, 2019, 1649423.
[http://dx.doi.org/10.1155/2019/1649423] [PMID: 31531345]

Li, C.; Zou, H.; Xiong, Z.; Xiong, Y.; Miyagishima, D.F.; Wanggou, S.; Li, X. Construction and validation of a 13-gene signature for prognosis prediction in medulloblastoma. Front. Genet., 2020, 11, 429.
[http://dx.doi.org/10.3389/fgene.2020.00429] [PMID: 32508873]

Cao, H.; Zhang, Y.; Zhao, J.; Zhu, L.; Wang, Y.; Li, J.; Feng, Y-M.; Zhang, N. Prediction of the ebola virus infection related human genes using protein-protein interaction network. Comb. Chem. High Throughput Screen., 2017, 20(7), 638-646.
[http://dx.doi.org/10.2174/1386207320666170310114816] [PMID: 28294056]

Zhang, N.; Jiang, M.; Huang, T.; Cai, Y.D. Identification of influenza A/H7N9 virus infection-related human genes based on shortest paths in a virus-human protein interaction network. Biomed Res. Int., 2014, 2014, 239462.
[http://dx.doi.org/10.1155/2014/239462] [PMID: 24955349]

Li, M.; Guo, Y.; Feng, Y-M.; Zhang, N. Identification of triple-negative breast cancer genes and a novel high-risk breast cancer prediction model development based on ppi data and support vector machines. Front. Genet., 2019, 10(MAR), 180.
[http://dx.doi.org/10.3389/fgene.2019.00180] [PMID: 30930932]

Liu, Q.; Wang, W.; Yang, X.; Zhao, D.; Li, F.; Wang, H. MicroRNA-146a inhibits cell migration and invasion by targeting RhoA in breast cancer. Oncol. Rep., 2016, 36(1), 189-196.
[http://dx.doi.org/10.3892/or.2016.4788] [PMID: 27175941]

Li, B.Q.; You, J.; Chen, L.; Zhang, J.; Zhang, N.; Li, H.P.; Huang, T.; Kong, X.Y.; Cai, Y.D. Identification of lung-cancer-related genes with the shortest path approach in a protein-protein interaction network. BioMed Res. Int., 2013, 2013, 267375.
[http://dx.doi.org/10.1155/2013/267375] [PMID: 23762832]

Li, B.Q.; Huang, T.; Zhang, J.; Zhang, N.; Huang, G.H.; Liu, L.; Cai, Y.D. An ensemble prognostic model for colorectal cancer. PLoS One, 2013, 8(5), e63494.
[http://dx.doi.org/10.1371/journal.pone.0063494] [PMID: 23658834]

van Vliet, M.H.; Horlings, H.M.; van de Vijver, M.J.; Reinders, M.J.T.; Wessels, L.F.A. Integration of clinical and gene expression data has a synergetic effect on predicting breast cancer outcome. PLoS One, 2012, 7(7), e40358.
[http://dx.doi.org/10.1371/journal.pone.0040358] [PMID: 22808140]

Ceccarelli, M.; Barthel, F.P.; Malta, T.M.; Sabedot, T.S.; Salama, S.R.; Murray, B.A.; Morozova, O.; Newton, Y.; Radenbaugh, A.; Pagnotta, S.M.; Anjum, S.; Wang, J.; Manyam, G.; Zoppoli, P.; Ling, S.; Rao, A.A.; Grifford, M.; Cherniack, A.D.; Zhang, H.; Poisson, L.; Carlotti, C.G., Jr; Tirapelli, D.P.D.C.; Rao, A.; Mikkelsen, T.; Lau, C.C.; Yung, W.K.A.; Rabadan, R.; Huse, J.; Brat, D.J.; Lehman, N.L.; Barnholtz-Sloan, J.S.; Zheng, S.; Hess, K.; Rao, G.; Meyerson, M.; Beroukhim, R.; Cooper, L.; Akbani, R.; Wrensch, M.; Haussler, D.; Aldape, K.D.; Laird, P.W.; Gutmann, D.H.; Noushmehr, H.; Iavarone, A.; Verhaak, R.G.; Balasundaram, M.; Balu, S.; Barnett, G.; Baylin, S.; Bell, S.; Benz, C.; Bir, N.; Black, K.L.; Bodenheimer, T.; Boice, L.; Bootwalla, M.S.; Bowen, J.; Bristow, C.A.; Butterfield, Y.S.N.; Chen, Q.R.; Chin, L.; Cho, J.; Chuah, E.; Chudamani, S.; Coetzee, S.G.; Cohen, M.L.; Colman, H.; Couce, M.; D’Angelo, F.; Davidsen, T.; Davis, A.; Demchok, J.A.; Devine, K.; Ding, L.; Duell, R.; Elder, J.B.; Eschbacher, J.M.; Fehrenbach, A.; Ferguson, M.; Frazer, S.; Fuller, G.; Fulop, J.; Gabriel, S.B.; Garofano, L.; Gastier-Foster, J.M.; Gehlenborg, N.; Gerken, M.; Getz, G.; Giannini, C.; Gibson, W.J.; Hadjipanayis, A.; Hayes, D.N.; Heiman, D.I.; Hermes, B.; Hilty, J.; Hoadley, K.A.; Hoyle, A.P.; Huang, M.; Jefferys, S.R.; Jones, C.D.; Jones, S.J.M.; Ju, Z.; Kastl, A.; Kendler, A.; Kim, J.; Kucherlapati, R.; Lai, P.H.; Lawrence, M.S.; Lee, S.; Leraas, K.M.; Lichtenberg, T.M.; Lin, P.; Liu, Y.; Liu, J.; Ljubimova, J.Y.; Lu, Y.; Ma, Y.; Maglinte, D.T.; Mahadeshwar, H.S.; Marra, M.A.; McGraw, M.; McPherson, C.; Meng, S.; Mieczkowski, P.A.; Miller, C.R.; Mills, G.B.; Moore, R.A.; Mose, L.E.; Mungall, A.J.; Naresh, R.; Naska, T.; Neder, L.; Noble, M.S.; Noss, A.; O’Neill, B.P.; Ostrom, Q.T.; Palmer, C.; Pantazi, A.; Parfenov, M.; Park, P.J.; Parker, J.S.; Perou, C.M.; Pierson, C.R.; Pihl, T.; Protopopov, A.; Radenbaugh, A.; Ramirez, N.C.; Rathmell, W.K.; Ren, X.; Roach, J.; Robertson, A.G.; Saksena, G.; Schein, J.E.; Schumacher, S.E.; Seidman, J.; Senecal, K.; Seth, S.; Shen, H.; Shi, Y.; Shih, J.; Shimmel, K.; Sicotte, H.; Sifri, S.; Silva, T.; Simons, J.V.; Singh, R.; Skelly, T.; Sloan, A.E.; Sofia, H.J.; Soloway, M.G.; Song, X.; Sougnez, C.; Souza, C.; Staugaitis, S.M.; Sun, H.; Sun, C.; Tan, D.; Tang, J.; Tang, Y.; Thorne, L.; Trevisan, F.A.; Triche, T.; Van Den Berg, D.J.; Veluvolu, U.; Voet, D.; Wan, Y.; Wang, Z.; Warnick, R.; Weinstein, J.N.; Weisenberger, D.J.; Wilkerson, M.D.; Williams, F.; Wise, L.; Wolinsky, Y.; Wu, J.; Xu, A.W.; Yang, L.; Yang, L.; Zack, T.I.; Zenklusen, J.C.; Zhang, J.; Zhang, W.; Zhang, J.; Zmuda, E.; Noushmehr, H.; Iavarone, A.; Verhaak, R.G.W. Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma. Cell, 2016, 164(3), 550-563.
[http://dx.doi.org/10.1016/j.cell.2015.12.028] [PMID: 26824661]

Zhao, Z.; Zhang, K-N.; Wang, Q.; Li, G.; Zeng, F.; Zhang, Y.; Wu, F.; Chai, R.; Wang, Z.; Zhang, C.; Zhang, W.; Bao, Z.; Jiang, T. Chinese glioma genome atlas (CGGA): A comprehensive resource with functional genomic data from chinese gliomas. Genomics Proteomics Bioinformatics, 2021. S1672-0229(21)00045-0
[PMID: 33662628]

Sun, Y.; Zhang, W.; Chen, D.; Lv, Y.; Zheng, J.; Lilljebjörn, H.; Ran, L.; Bao, Z.; Soneson, C.; Sjögren, H.O.; Salford, L.G.; Ji, J.; French, P.J.; Fioretos, T.; Jiang, T.; Fan, X. A glioma classification scheme based on coexpression modules of EGFR and PDGFRA. Proc. Natl. Acad. Sci. USA, 2014, 111(9), 3538-3543.
[http://dx.doi.org/10.1073/pnas.1313814111] [PMID: 24550449]

Ahmad, F.K.; Deris, S.; Othman, N.H. Toward integrated clinical and gene- expression profiles for breast cancer prognosis: A review paper. Int. J. Biometrics Bioinforma., 2009, 3(4), 31-47.

Spina, R.; Voss, D.M.; Asnaghi, L.; Sloan, A.; Bar, E.E. Atracurium Besylate and other neuromuscular blocking agents promote astroglial differentiation and deplete glioblastoma stem cells. Oncotarget, 2016, 7(1), 459-472.
[http://dx.doi.org/10.18632/oncotarget.6314] [PMID: 26575950]

Zamorano, A.; Lamas, M.; Vergara, P.; Naranjo, J.R.; Segovia, J. Transcriptionally mediated gene targeting of gas1 to glioma cells elicits growth arrest and apoptosis. J. Neurosci. Res., 2003, 71(2), 256-263.
[http://dx.doi.org/10.1002/jnr.10461] [PMID: 12503088]

Wijethilake, N.; Islam, M.; Ren, H. Radiogenomics model for overall survival prediction of glioblastoma. Med. Biol. Eng. Comput., 2020, 58(8), 1767-1777.
[http://dx.doi.org/10.1007/s11517-020-02179-9] [PMID: 32488372]

Qi, C.; Lei, L.; Hu, J.; Wang, G.; Liu, J.; Ou, S. Serine incorporator 2 (serinc2) expression predicts an unfavorable prognosis of low-grade glioma (LGG): Evidence from bioinformatics analysis. J. Mol. Neurosci., 2020, 70(10), 1521-1532.
[http://dx.doi.org/10.1007/s12031-020-01620-w] [PMID: 32642801]

Bao, Z.S.; Chen, H.M.; Yang, M.Y.; Zhang, C.B.; Yu, K.; Ye, W.L.; Hu, B.Q.; Yan, W.; Zhang, W.; Akers, J.; Ramakrishnan, V.; Li, J.; Carter, B.; Liu, Y.W.; Hu, H.M.; Wang, Z.; Li, M.Y.; Yao, K.; Qiu, X.G.; Kang, C.S.; You, Y.P.; Fan, X.L.; Song, W.S.; Li, R.Q.; Su, X.D.; Chen, C.C.; Jiang, T. RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas. Genome Res., 2014, 24(11), 1765-1773.
[http://dx.doi.org/10.1101/gr.165126.113] [PMID: 25135958]

Zhao, Z.; Meng, F.; Wang, W.; Wang, Z.; Zhang, C.; Jiang, T. Comprehensive RNA-seq transcriptomic profiling in the malignant progression of gliomas. Sci. Data, 2017, 4, 170024.
[http://dx.doi.org/10.1038/sdata.2017.24] [PMID: 28291232]

Liu, X.; Li, Y.; Qian, Z.; Sun, Z.; Xu, K.; Wang, K.; Liu, S.; Fan, X.; Li, S.; Zhang, Z.; Jiang, T.; Wang, Y. A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas. Neuroimage Clin., 2018, 20, 1070-1077.
[http://dx.doi.org/10.1016/j.nicl.2018.10.014] [PMID: 30366279]

Wang, Y.; Qian, T.; You, G.; Peng, X.; Chen, C.; You, Y.; Yao, K.; Wu, C.; Ma, J.; Sha, Z.; Wang, S.; Jiang, T. Localizing seizure-susceptible brain regions associated with low-grade gliomas using voxel-based lesion-symptom mapping. Neuro-oncol., 2015, 17(2), 282-288.
[http://dx.doi.org/10.1093/neuonc/nou130] [PMID: 25031032]

Leek, J.T.; Scharpf, R.B.; Bravo, H.C.; Simcha, D.; Langmead, B.; Johnson, W.E.; Geman, D.; Baggerly, K.; Irizarry, R.A. Tackling the widespread and critical impact of batch effects in high-throughput data. Nat. Rev. Genet., 2010, 11(10), 733-739.
[http://dx.doi.org/10.1038/nrg2825] [PMID: 20838408]

Leek, J.T.; Johnson, W.E.; Parker, H.S.; Fertig, E.J.; Jaffe, A.E.; Zhang, Y.; Storey, J.D. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics, 2012, 28(6), 882-3.

Lin, H.; Zelterman, D. Modeling survival data: Extending the cox model. Technometrics, 2002, 44(1), 85-86.
[http://dx.doi.org/10.1198/tech.2002.s656]

Kosinski, M.; Kassambara, A.; Biecek, P. Drawing survival curves using “Ggplot2.” R package version 0.4.7., 2020. Available from: https://CRAN.R-project.org/package=survminer

Simon, N.; Friedman, J.; Hastie, T.; Tibshirani, R. Regularization paths for cox’s proportional hazards model via coordinate descent. J. Stat. Softw., 2011, 39(5), 1-13.
[http://dx.doi.org/10.18637/jss.v039.i05] [PMID: 27065756]

Therneau, T.M.; Grambsch, P.M. The cox model.Statistics for biology and health; John Wiley & Sons. Ltd, 2000, 20, 39-77.

Pedregosa, F.; Varoquaux, G.; Gramfort, A.; Michel, V.; Thirion, B.; Grisel, O.; Blondel, M.; Prettenhofer, P.; Weiss, R.; Dubourg, V.; Vanderplas, J.; Passos, A.; Cournapeau, D.; Brucher, M.; Perrot, M.; Duchesnay, É. Scikit-learn: Machine learning in python. J. Mach. Learn. Res., 2011, 12, 2825-2830.

Van Der Walt, S.; Colbert, S.C.; Varoquaux, G. The Numpy array: A structure for efficient numerical computation. Comput. Sci. Eng., 2011, 13(2), 22-30.
[http://dx.doi.org/10.1109/MCSE.2011.37]

Li, J.; Pu, Y.; Tang, J.; Zou, Q.; Guo, F. DeepAVP: A dual-channel deep neural network for identifying variable-length antiviral peptides. IEEE J. Biomed. Health Inform., 2020, 24(10), 3012-3019.
[http://dx.doi.org/10.1109/JBHI.2020.2977091] [PMID: 32142462]

Lv, Z.; Ding, H.; Wang, L.; Zou, Q. A convolutional neural network using dinucleotide one-hot encoder for identifying DNA N6-methyladenine sites in the rice genome. Neurocomputing, 2021, 422(4), 214-221.
[http://dx.doi.org/10.1016/j.neucom.2020.09.056]

Mostavi, M.; Chiu, Y.C.; Huang, Y.; Chen, Y. Convolutional neural network models for cancer type prediction based on gene expression. BMC Med. Genomics, 2020, 13(S5), 44.
[http://dx.doi.org/10.1186/s12920-020-0677-2] [PMID: 32241303]

Chen, L.; Pan, X.; Zhang, Y.H.; Liu, M.; Huang, T.; Cai, Y.D. Classification of widely and rarely expressed genes with recurrent neural network. Comput. Struct. Biotechnol. J., 2018, 17, 49-60.
[http://dx.doi.org/10.1016/j.csbj.2018.12.002] [PMID: 30595815]

Bergstra, J.; Bengio, Y. Random search for hyper-parameter optimization. J. Mach. Learn. Res. 2012, 13(null), 281-305.

Friedman, J.; Hastie, T.; Tibshirani, R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw., 2010, 33(1), 1-22.
[http://dx.doi.org/10.18637/jss.v033.i01] [PMID: 20808728]

Kemp, F. Modern applied statistics with S, 4th. Springer, 2003, 52.

Kingma, D.P.; Ba, J.L. Adam: A method for stochastic optimization. 3rd Int. Conf. Learn. Represent. ICLR 2015 - Conf. Track Proc., 2015.

Yu, G.; Wang, L.G.; Han, Y.; He, Q.Y. Cluster profiler: an R package for comparing biological themes among gene clusters. Omi. A J. Integr. Biol., 2012, 16(5), 284-287.
[http://dx.doi.org/10.1089/omi.2011.0118] [PMID: 22455463]

Carlson, M. Genome wide annotation for human; Bioconducter, 2019.
[http://dx.doi.org/10.18129/B9.bioc.org.Hs.eg.db]

Eisen, M.B.; Spellman, P.T.; Brown, P.O.; Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA, 1998, 95(25), 14863-14868.
[http://dx.doi.org/10.1073/pnas.95.25.14863] [PMID: 9843981]

Durinck, S.; Spellman, P.T.; Birney, E.; Huber, W. Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt. Nat. Protoc., 2009, 4(8), 1184-1191.
[http://dx.doi.org/10.1038/nprot.2009.97] [PMID: 19617889]

Arai, E.; Gotoh, M.; Tian, Y.; Sakamoto, H.; Ono, M.; Matsuda, A.; Takahashi, Y.; Miyata, S.; Totsuka, H.; Chiku, S.; Komiyama, M.; Fujimoto, H.; Matsumoto, K.; Yamada, T.; Yoshida, T.; Kanai, Y. Alterations of the spindle checkpoint pathway in clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas. Int. J. Cancer, 2015, 137(11), 2589-2606.
[http://dx.doi.org/10.1002/ijc.29630] [PMID: 26061684]

Etcheverry, A.; Aubry, M.; de Tayrac, M.; Vauleon, E.; Boniface, R.; Guenot, F.; Saikali, S.; Hamlat, A.; Riffaud, L.; Menei, P.; Quillien, V.; Mosser, J. DNA methylation in glioblastoma: Impact on gene expression and clinical outcome. BMC Genomics, 2010, 11(1), 701.
[http://dx.doi.org/10.1186/1471-2164-11-701] [PMID: 21156036]

Bruyère, C.; Meijer, L. Targeting cyclin-dependent kinases in anti-neoplastic therapy. Curr. Opin. Cell Biol., 2013, 25(6), 772-779.
[http://dx.doi.org/10.1016/j.ceb.2013.08.004] [PMID: 24011867]

Biedler, J.L.; Roffler-Tarlov, S.; Schachner, M.; Freedman, L.S. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res.,, 1978. 38(11 Pt1), 3751-3757.
[PMID: 29704]

Sinkus, M. L.; Graw, S.; Freedman, R.; Ross, R. G.; Lester, H. A.; Leonard, S. The human chrna7 and chrfam7a genes: A review of the genetics, regulation, and function. Neuropharmacology,, 2015, 96(PB), 274-288.

Tsai, Y-S.; Lin, C-T.; Tseng, G.C.; Chung, I-F.; Pal, N.R. Discovery of dominant and dormant genes from expression data using a novel generalization of SNR for multi-class problems. BMC Bioinformatics, 2008, 9(1), 425.
[http://dx.doi.org/10.1186/1471-2105-9-425] [PMID: 18842155]

Wang, J.; Lin, Z.J.; Liu, L.; Xu, H.Q.; Shi, Y.W.; Yi, Y.H.; He, N.; Liao, W.P. Epilepsy-associated genes. Seizure, 2017, 44, 11-20.
[http://dx.doi.org/10.1016/j.seizure.2016.11.030] [PMID: 28007376]

Guo, W.; Zhu, L.; Yu, M.; Zhu, R.; Chen, Q.; Wang, Q. A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinoma. Clin. Epigenetics, 2018, 10(1), 142.
[http://dx.doi.org/10.1186/s13148-018-0574-0] [PMID: 30446011]

Wakabayashi, T.; Natsume, A.; Hashizume, Y.; Fujii, M.; Mizuno, M.; Yoshida, J. A phase I clinical trial of interferon-beta gene therapy for high-grade glioma: Novel findings from gene expression profiling and autopsy. J. Gene Med., 2008, 10(4), 329-339.
[http://dx.doi.org/10.1002/jgm.1160] [PMID: 18220319]

Liu, W.; Xu, Z.; Zhou, J.; Xing, S.; Li, Z.; Gao, X.; Feng, S.; Xiao, Y. High levels of hist1h2bk in low-grade glioma predicts poor prognosis: A study using cgga and tcga data. Front. Oncol., 2020, 10, 627.
[http://dx.doi.org/10.3389/fonc.2020.00627] [PMID: 32457836]

MacLeod, D.; Dowman, J.; Hammond, R.; Leete, T.; Inoue, K.; Abeliovich, A. The familial Parkinsonism gene LRRK2 regulates neurite process morphology. Neuron, 2006, 52(4), 587-593.
[http://dx.doi.org/10.1016/j.neuron.2006.10.008] [PMID: 17114044]

Fig. Method of analysing a blood sample of a subject for the presence of a disease marker. Google Patents, 2019.

Zhou, Y.; Fu, X.; Zheng, Z.; Ren, Y.; Zheng, Z.; Zhang, B.; Yuan, M.; Duan, J.; Li, M.; Hong, T.; Lu, G.; Zhou, D. Identification of gene co-expression modules and hub genes associated with the invasiveness of pituitary adenoma. Endocrine, 2020, 68(2), 377-389.
[http://dx.doi.org/10.1007/s12020-020-02316-2] [PMID: 32342269]

Aguilar-Morante, D.; Morales-Garcia, J.A.; Santos, A.; Perez-Castillo, A. CCAAT/enhancer binding protein β induces motility and invasion of glioblastoma cells through transcriptional regulation of the calcium binding protein S100A4. Oncotarget, 2015, 6(6), 4369-4384.
[http://dx.doi.org/10.18632/oncotarget.2976] [PMID: 25738360]

Du, C.; Pan, P.; Jiang, Y.; Zhang, Q.; Bao, J.; Liu, C. Microarray data analysis to identify crucial genes regulated by CEBPB in human SNB19 glioma cells. World J. Surg. Oncol., 2016, 14(1), 258.
[http://dx.doi.org/10.1186/s12957-016-0997-z] [PMID: 27716259]

Hnoonual, A.; Thammachote, W.; Tim-Aroon, T.; Rojnueangnit, K.; Hansakunachai, T.; Sombuntham, T.; Roongpraiwan, R.; Worachotekamjorn, J.; Chuthapisith, J.; Fucharoen, S.; Wattanasirichaigoon, D.; Ruangdaraganon, N.; Limprasert, P.; Jinawath, N. Chromosomal microarray analysis in a cohort of underrepresented population identifies SERINC2 as a novel candidate gene for autism spectrum disorder. Sci. Rep., 2017, 7(1), 12096.
[http://dx.doi.org/10.1038/s41598-017-12317-3] [PMID: 28935972]

Cortez, M.A.; Anfossi, S.; Ramapriyan, R.; Menon, H.; Atalar, S.C.; Aliru, M.; Welsh, J.; Calin, G.A. Role of miRNAs in immune responses and immunotherapy in cancer. Genes Chromosomes Cancer, 2019, 58(4), 244-253.
[http://dx.doi.org/10.1002/gcc.22725] [PMID: 30578699]

Topalian, S.L.; Drake, C.G.; Pardoll, D.M. Immune checkpoint blockade: A common denominator approach to cancer therapy. Cancer Cell, 2015, 27(4), 450-461.
[http://dx.doi.org/10.1016/j.ccell.2015.03.001] [PMID: 25858804]

Zhou, J.; Liu, M.; Sun, H.; Feng, Y.; Xu, L.; Chan, A.W.H.; Tong, J.H.; Wong, J.; Chong, C.C.N.; Lai, P.B.S.; Wang, H.K.S.; Tsang, S.W.; Goodwin, T.; Liu, R.; Huang, L.; Chen, Z.; Sung, J.J.Y.; Chow, K.L.; To, K.F.; Cheng, A.S.L. Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy. Gut, 2018, 67(5), 931-944.
[http://dx.doi.org/10.1136/gutjnl-2017-314032] [PMID: 28939663]